title: Regulations' Impact on Donor and Recipient Selection for Liver Transplantation: How Should Outcomes be Measured and MELD Exception Scores be Considered?
authors.forename: Joel T
authors.initials: JT
authors.lastname: Adler
authors.affiliation: Section chief of solid organ transplant surgery at Dartmouth-Hitchcock Medical Center and an associate professor of surgery at the Geisel School of Medicine at Dartmouth College in Hanover, New Hampshire, and a regional councilor for the United Network of Organ Sharing (UNOS) and a member of the Organ Procurement and Transplantation Network/UNOS Membership and Professional Standards Committee.
authors.forename: David A
authors.initials: DA
authors.lastname: Axelrod
mesh_terms: D058625:End Stage Liver Disease / Q000175:diagnosis / Q000601:surgery*; D033161:Government Regulation; D006084:Graft Rejection / Q000209:etiology / Q000401:mortality; D006801:Humans; D007882:Legislation, Hospital / Q000639:trends; D016031:Liver Transplantation / Q000941:ethics / Q000331:legislation & jurisprudence / Q000401:mortality / Q000592:standards / Q000639:trends; D006278:Medicare; D017063:Outcome Assessment, Health Care / Q000379:methods* / Q000592:standards / Q000639:trends; D018579:Patient Selection / Q000941:ethics; D055031:Primary Graft Dysfunction / Q000209:etiology / Q000401:mortality; D040841:Resource Allocation / Q000941:ethics / Q000331:legislation & jurisprudence / Q000379:methods / Q000592:standards / Q000639:trends; D018570:Risk Assessment; D012307:Risk Factors; D012720:Severity of Illness Index; D014019:Tissue Donors; D017211:Treatment Failure; D014481:United States; D014850:Waiting Lists